Opthea

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Opthea and other ETFs, options, and stocks.

About OPT

Opthea Ltd. is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. 

CEO
Megan Baldwin
CEOMegan Baldwin
Employees
Employees
Headquarters
South Yarra, Victoria (VIC)
HeadquartersSouth Yarra, Victoria (VIC)
Founded
1984
Founded1984
Employees
Employees

OPT Key Statistics

Market cap
304.34M
Market cap304.34M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
2.76K
Average volume2.76K
High today
$6.19
High today$6.19
Low today
$5.82
Low today$5.82
Open price
$6.19
Open price$6.19
Volume
15.14K
Volume15.14K
52 Week high
$8.50
52 Week high$8.50
52 Week low
$4.73
52 Week low$4.73

OPT Earnings

-$5.50
-$2.66
$0.17
$3.01
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
per share
Estimated per share
Actual
Available Aug 30, Pre-Market
ActualAvailable Aug 30, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.